These observations are consistent with our data demonstrating a significant competitive advantage of TET2-null human cells to populate the spleen of engrafted animals and also that the index patient (UPN01) reported herein presented with splenomegaly and extramedullary disease. Here, TET2 is linked to Splenomegaly.